Austco Healthcare
- Short interest
- 0.00%
- −0.01 pp 30d
- as of 19 June 2026
- Reported shorts
- 1.2K
- Shares on issue
- 374.751M
Austco Healthcare (AHC) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $94.2Mvs $81.4M (FY25)
- Yahoo Finance, as at 14 Oct 2026
- NPAT
- $9.0Mvs $5.9M (FY25)
- Yahoo Finance, as at 14 Oct 2026
- EPS (diluted)
- $0.024vs $0.016 (FY25)
- Yahoo Finance, as at 14 Oct 2026
- Rev YoY
- +15.8%FY
- EPS YoY
- +48.8%FY
Summary of Annual Report to shareholders, 17 Sep 2026
Austco Healthcare delivered record FY26 revenue of $94.2 million (up 16%) and net profit of $9.0 million (up 52%). No dividend was declared. The company enters FY27 with $51.2 million in unfilled contracted revenue and expects further margin improvement from integration and lower input costs.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 14 Oct 2026
- Gross margin
- 53.4%
- Operating margin
- 11.4%
- Net margin
- 9.6%
- FCF margin
- 10.3%
- ROE
- 15.8%
- ROA
- 10.0%
- FCF conversion
- 1.08×
- Net cash (excl. leases)
- $16.1M
- Net debt / EBITDA
- −1.0×
- Current ratio
- 2.1×
- Interest cover
- >100×
- Cash dividends paid / net profit
- n/a
- Market cap
- $88.1M
- P/E
- 9.9×
- P/B
- 1.4×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $94.2M | $81.4M | $58.2M | $42.0M |
| Gross profit | $50.3M | $42.4M | $30.7M | $22.4M |
| Operating income | $10.8M | $10.0M | $5.8M | $1.8M |
| EBITDA | $15.6M | $10.9M | $8.0M | $3.6M |
| EBIT | $11.6M | $8.1M | $5.7M | $1.8M |
| Interest expense | $9.0K | $16.0K | $48.0K | $22.0K |
| Pretax income | $11.6M | $8.1M | $5.7M | $1.8M |
| Tax | $2.6M | $2.1M | −$1.4M | −$443.0K |
| NPAT | $9.0M | $5.9M | $7.1M | $2.3M |
| Net interest income | −$215.0K | $95.0K | −$86.0K | −$29.0K |
| EPS basic | $0.024 | $0.016 | $0.023 | $0.008 |
| EPS diluted | $0.024 | $0.016 | $0.023 | $0.008 |
| Shares | 374.8M | 360.8M | 360.8M | 291.4M |
Financial reports
The company's own filings, newest first
- Annual Report to shareholdersAnnual Report17 Sep 2026via asx_announcements
- Appendix 4E & FY26 Financial StatementsAnnual Results27 Aug 2026via asx_announcements
- Half Year results investor presentationHalf Year Results18 Feb 2026via asx_announcements
- Half Year results media releaseHalf Year Results18 Feb 2026via asx_announcements
- Appendix 4D and 1HFY26 AccountsHalf Year Results18 Feb 2026via asx_announcements
- Annual Report to shareholdersAnnual Report17 Sep 2025via asx_announcements
- Appendix 4E & FY25 Financial StatementsAnnual Results26 Aug 2025via asx_announcements
- Austco Healthcare Appendix 4D and HY Dec 24 ResultsHalf Year Results27 Feb 2025via asx_announcements
- Annual Report to shareholdersAnnual Report23 Sep 2024via asx_announcements
- Appendix 4E & FY24 Financial StatementsAnnual Results29 Aug 2024via asx_announcements
Showing 10 of 11 reports